![Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | SpringerLink Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00296-009-1313-9/MediaObjects/296_2009_1313_Fig3_HTML.gif)
Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | SpringerLink
![Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis | The Journal of Rheumatology Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/47/1/35/F1.large.jpg)
Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis: A German GO-NICE Study Subanalysis | The Journal of Rheumatology
![Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | SpringerLink Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00296-009-1313-9/MediaObjects/296_2009_1313_Fig1_HTML.gif)
Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | SpringerLink
![Frontiers | The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis Frontiers | The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis](https://www.frontiersin.org/files/Articles/856654/fmed-09-856654-HTML/image_m/fmed-09-856654-t002.jpg)
Frontiers | The BASDAI Cut-Off for Disease Activity Corresponding to the ASDAS Scores in a Taiwanese Cohort of Ankylosing Spondylitis
![PDF) Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | Li Li H.k - Academia.edu PDF) Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | Li Li H.k - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/75999485/mini_magick20211209-10996-1ovdqco.png?1639048022)
PDF) Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | Li Li H.k - Academia.edu
![Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | SpringerLink Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00296-009-1313-9/MediaObjects/296_2009_1313_Fig2_HTML.gif)
Multicenter validation of the value of BASFI and BASDAI in Chinese ankylosing spondylitis and undifferentiated spondyloarthropathy patients | SpringerLink
![PDF) The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis PDF) The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis](https://i1.rgstatic.net/publication/304008906_The_Minimum_Clinically_Important_Improvement_and_Patient-acceptable_Symptom_State_in_the_BASDAI_and_BASFI_for_Patients_with_Ankylosing_Spondylitis/links/576a314208ae1a43d23a3fd4/largepreview.png)
PDF) The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis
![Comorbidity and physical function: variables associated with BASFI in... | Download Scientific Diagram Comorbidity and physical function: variables associated with BASFI in... | Download Scientific Diagram](https://www.researchgate.net/publication/332734600/figure/tbl1/AS:764313937661952@1559238051593/Comorbidity-and-physical-function-variables-associated-with-BASFI-in-patients-with-AS.png)
Comorbidity and physical function: variables associated with BASFI in... | Download Scientific Diagram
![PDF) Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing PDF) Defining disease status in ankylosing spondylitis: validation and cross-cultural adaptation of the Arabic Bath Ankylosing Spondylitis Functional Index (BASFI), the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), and the Bath Ankylosing](https://0.academia-photos.com/attachment_thumbnails/68208414/mini_magick20210720-4145-16bj233.png?1626781379)